BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28003334)

  • 1. HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation.
    Myant KB; Cammareri P; Hodder MC; Wills J; Von Kriegsheim A; Győrffy B; Rashid M; Polo S; Maspero E; Vaughan L; Gurung B; Barry E; Malliri A; Camargo F; Adams DJ; Iavarone A; Lasorella A; Sansom OJ
    EMBO Mol Med; 2017 Feb; 9(2):181-197. PubMed ID: 28003334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models.
    Kunz V; Bommert KS; Kruk J; Schwinning D; Chatterjee M; Stühmer T; Bargou R; Bommert K
    Sci Rep; 2020 Oct; 10(1):18419. PubMed ID: 33116152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MULE/HUWE1 E3 ubiquitin ligase is a tumor suppressor.
    Cancer Discov; 2013 Jul; 3(7):OF32. PubMed ID: 23847377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
    Bonazzoli E; Bellone S; Zammataro L; Gnutti B; Guglielmi A; Pelligra S; Nagarkatti N; Manara P; Tymon-Rosario J; Zeybek B; Altwerger G; Menderes G; Han C; Ratner E; Silasi DA; Huang GS; Andikyan V; Azodi M; Schwartz PE; Santin AD
    Gynecol Oncol; 2020 Sep; 158(3):769-775. PubMed ID: 32600791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc.
    Qu H; Liu H; Jin Y; Cui Z; Han G
    Biomed Pharmacother; 2018 Oct; 106():309-315. PubMed ID: 29966975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma.
    Crawford LJ; Campbell DC; Morgan JJ; Lawson MA; Down JM; Chauhan D; McAvera RM; Morris TC; Hamilton C; Krishnan A; Rajalingam K; Chantry AD; Irvine AE
    Oncogene; 2020 Jul; 39(27):5001-5014. PubMed ID: 32523091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.
    Inoue S; Hao Z; Elia AJ; Cescon D; Zhou L; Silvester J; Snow B; Harris IS; Sasaki M; Li WY; Itsumi M; Yamamoto K; Ueda T; Dominguez-Brauer C; Gorrini C; Chio II; Haight J; You-Ten A; McCracken S; Wakeham A; Ghazarian D; Penn LJ; Melino G; Mak TW
    Genes Dev; 2013 May; 27(10):1101-14. PubMed ID: 23699408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase.
    Peter S; Bultinck J; Myant K; Jaenicke LA; Walz S; Müller J; Gmachl M; Treu M; Boehmelt G; Ade CP; Schmitz W; Wiegering A; Otto C; Popov N; Sansom O; Kraut N; Eilers M
    EMBO Mol Med; 2014 Dec; 6(12):1525-41. PubMed ID: 25253726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.
    Qi CF; Kim YS; Xiang S; Abdullaev Z; Torrey TA; Janz S; Kovalchuk AL; Sun J; Chen D; Cho WC; Gu W; Morse Iii HC
    Int J Mol Sci; 2012; 13(5):6204-6219. PubMed ID: 22754359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain.
    Zhao X; D' Arca D; Lim WK; Brahmachary M; Carro MS; Ludwig T; Cardo CC; Guillemot F; Aldape K; Califano A; Iavarone A; Lasorella A
    Dev Cell; 2009 Aug; 17(2):210-21. PubMed ID: 19686682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression.
    Yuan Y; Wang LH; Zhao XX; Wang J; Zhang MS; Ma QH; Wei S; Yan ZX; Cheng Y; Chen XQ; Zou HB; Ge J; Wang Y; Zhang X; Cui YH; Luo T; Bian XW
    Cancer Commun (Lond); 2022 Sep; 42(9):868-886. PubMed ID: 35848447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein.
    Zhao X; Heng JI; Guardavaccaro D; Jiang R; Pagano M; Guillemot F; Iavarone A; Lasorella A
    Nat Cell Biol; 2008 Jun; 10(6):643-53. PubMed ID: 18488021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.
    Yang D; Cheng D; Tu Q; Yang H; Sun B; Yan L; Dai H; Luo J; Mao B; Cao Y; Yu X; Jiang H; Zhao X
    Theranostics; 2018; 8(13):3517-3529. PubMed ID: 30026863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53.
    Kurokawa M; Kim J; Geradts J; Matsuura K; Liu L; Ran X; Xia W; Ribar TJ; Henao R; Dewhirst MW; Kim WJ; Lucas JE; Wang S; Spector NL; Kornbluth S
    Sci Signal; 2013 May; 6(274):ra32. PubMed ID: 23652204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour suppressive function of HUWE1 in thyroid cancer.
    Ma W; Zhao P; Zang L; Zhang K; Liao H; Hu Z
    J Biosci; 2016 Sep; 41(3):395-405. PubMed ID: 27581931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solenoid architecture of HUWE1 contributes to ligase activity and substrate recognition.
    Hunkeler M; Jin CY; Ma MW; Monda JK; Overwijn D; Bennett EJ; Fischer ES
    Mol Cell; 2021 Sep; 81(17):3468-3480.e7. PubMed ID: 34314700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination by HUWE1 in tumorigenesis and beyond.
    Kao SH; Wu HT; Wu KJ
    J Biomed Sci; 2018 Sep; 25(1):67. PubMed ID: 30176860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer.
    Gong X; Du D; Deng Y; Zhou Y; Sun L; Yuan S
    Invest New Drugs; 2020 Apr; 38(2):515-524. PubMed ID: 32008177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRL4B
    Liu F; Cao L; Zhang T; Chang F; Xu Y; Li Q; Deng J; Li L; Shao G
    Biochem Biophys Res Commun; 2018 Jun; 501(2):440-447. PubMed ID: 29738775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobramycin suppresses HUWE1 degradation to control MCL-1 stability during tumour development.
    He J; Wu S; Li X; Tang L; Chen H; Qin L; Xie J; Lu T; Xu W
    Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1600-1610. PubMed ID: 32378766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.